The National Viral Hepatitis Control Programme (NVHCP) has completed eight years since its nationwide rollout in 2016, representing a major public health initiative aimed at controlling and eventually eliminating viral hepatitis as a public health threat in India. This milestone offers an opportunity to reflect on the programme's achievements and the ongoing challenges in combating a disease that affects millions of Indians.
Understanding Viral Hepatitis
Viral hepatitis refers to inflammation of the liver caused by viral infections, primarily hepatitis B and C viruses. These infections can lead to serious complications including liver cirrhosis, liver failure, and hepatocellular carcinoma. Unlike hepatitis A and E, which are typically acute and spread through contaminated food and water, hepatitis B and C are bloodborne infections that can become chronic and cause long-term liver damage.
India carries a significant burden of viral hepatitis, with an estimated 40 million people living with hepatitis B and 6-12 million with hepatitis C. The disease often remains asymptomatic for years, leading to late diagnosis and treatment, which increases the risk of serious complications.
Programme Objectives and Structure
The NVHCP was launched with ambitious goals aligned with the World Health Organization's Global Health Sector Strategy to eliminate viral hepatitis as a public health threat by 2030. The programme focuses on several key areas:
- Prevention of transmission through vaccination and safe injection practices
- Screening and diagnosis of infected individuals
- Providing free treatment to those diagnosed with viral hepatitis
- Building capacity and infrastructure at healthcare facilities
- Raising awareness about hepatitis prevention and treatment
The programme operates through a network of healthcare facilities across the country, including designated viral hepatitis treatment centers at district and tertiary care levels.
Key Achievements
Over the past eight years, the NVHCP has made substantial progress in expanding access to screening and treatment. The programme has screened millions of individuals for hepatitis B and C, identifying many who were previously unaware of their infection status. This early detection is crucial for preventing disease progression and transmission.
One of the programme's most significant achievements has been making antiviral treatment accessible and affordable. Direct-acting antivirals for hepatitis C, which once cost prohibitively high amounts, are now available free of charge at government facilities. Similarly, treatment for hepatitis B has been expanded, helping prevent disease progression in infected individuals.
The integration of hepatitis B vaccination into the Universal Immunization Programme has been another milestone, with birth-dose vaccination helping prevent mother-to-child transmission and protecting newborns from infection.
Remaining Challenges
Despite progress, several challenges persist in the fight against viral hepatitis in India. Low awareness remains a significant barrier, with many people unaware of their infection status or the availability of free treatment. The asymptomatic nature of chronic hepatitis means that many infected individuals do not seek testing until complications develop.
Access to diagnostic facilities, particularly in rural and remote areas, continues to be limited. While urban centers have seen improved infrastructure, reaching underserved populations requires further expansion of testing and treatment facilities.
Stigma associated with viral hepatitis also hinders screening and treatment uptake. Many people fear social discrimination or believe the disease is untreatable, preventing them from seeking care.
The Road Ahead
To achieve the 2030 elimination goals, the programme needs sustained political commitment, adequate funding, and continued expansion of services. Strategies should focus on:
- Intensifying awareness campaigns to encourage voluntary testing
- Strengthening diagnostic networks in underserved areas
- Improving surveillance systems to track disease burden accurately
- Enhancing training for healthcare workers on hepatitis management
- Integrating hepatitis services with other health programmes for better reach
The eight-year milestone of the National Viral Hepatitis Control Programme represents significant progress in India's public health landscape. While substantial work remains, the foundation has been laid for achieving hepatitis elimination, potentially saving millions of lives and preventing countless cases of liver disease in the coming years.
This article provides general information about the National Viral Hepatitis Control Programme and viral hepatitis. It is not intended as medical advice. Individuals concerned about hepatitis should consult qualified healthcare professionals for proper diagnosis, treatment, and medical guidance.
===END===
